Pfizer kicks off human testing with maternal GBS vaccine

20th June 2017 Uncategorised 0

Though blockbuster vaccine Prevnar 13 is still the backbone of Pfizer’s portfolio, its declining sales have prompted the Big Pharma to explore other opportunities to compensate the loss, and a vaccine against Group B streptococcus is one of them.

More: Pfizer kicks off human testing with maternal GBS vaccine
Source: fierce